BIIB vs DXCM
Biogen vs Dexcom — AI-powered side-by-side comparison
| Metric | BIIB | DXCM |
|---|---|---|
| AI Score | 59 | 58 |
| Price | $197.66 | $71.44 |
| P/E Ratio | 21.68× | 31.15× |
| ROE | 0.1% | 0.3% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.7% | 0.6% |
| Debt / Equity | 0.35× | 0.47× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 50.0 | 52.3 |
| Beta | 0.158 | 1.453 |
| Expected Upside | +1.3% | +1.6% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BIIB Full Analysis
DXCM Full Analysis